Volume 83, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



Because some febrile patients are unable to swallow or retain oral antipyretic drugs, we carried out a double-blind, placebo-controlled trial in which intravenous ibuprofen (IV-ibuprofen) was given to adults hospitalized with fever associated with acute uncomplicated falciparum malaria treated with oral artesunate plus mefloquine. Thirty patients received IV-ibuprofen 400 mg and 30 received placebo every 6 hours for 72 hours. Reduction in the area above 37.0°C versus time curve was significantly greater for IV-ibuprofen than for placebo during the first 72 hours after first administration. No patients developed severe malaria; parasite clearance was delayed in the patients whose fevers were controlled by IV-ibuprofen (median 37.3 hours versus 23.7 hours in the placebo group [ = 0.0024]). This difference did not appear to be clinically important Adverse events, none considered severe, occurred equally in both groups. IV-ibuprofen was effective and well tolerated in reducing fever in febrile inpatients with malaria.


Article metrics loading...

Loading full text...

Full text loading...



  1. Looareesuwan S, , 1992. Overview: pathophysiology and management of cerebral malaria. Southeast Asian J Trop Med Public Health 23 (Suppl 4): 155165.
  2. Patel CC, , 1971. Acute febrile encephalopathy in Ugandan children. Afr J Med Sci 2: 127134.
  3. Young GB, , 2009. Coma. Ann NY Acad Sci 1157: 3247.[Crossref]
  4. Looareesuwan S, Phillips RE, White NJ, Kietinun S, Karbwang J, Rackow C, Turner RC, Warrell DA, , 1985. Quinine and severe falciparum malaria in late pregnancy. Lancet 2: 48.[Crossref]
  5. Warrell DA, Molyneux ME, Beales PF, , 1990. Severe and complicated malaria. Trans Roy Soc Trop Med Hyg 84 (Suppl 2): 165.
  6. Hemmer CJ, Kern P, Holst FG, Nawroth PP, Dietrich M, , 1991. Neither heparin nor acetylsalicylic acid influence the clinical course in human Plasmodium falciparum malaria: a prospective randomized study. Am J Trop Med Hyg 45: 608612.
  7. Schönhöfer P, Offerhaus L, Herxheimer A, , 2003. Dipyrone and agranulocytosis: what is the risk? Lancet Mar 361: 968969.[Crossref]
  8. Schwartz JI, Chan CC, Mukhopadhyay S, McBride KJ, Jones TM, Adcock S, Moritz C, Hedges J, Grasing K, Dobratz D, Cohen RA, Davidson MH, Bachmann KA, Gertz BJ, , 1999. Cyclooxygenase-2 inhibition by rofecoxib reverses naturally occurring fever in humans. Clin Pharmacol Ther 65: 653660.[Crossref]
  9. Bernard GR, Wheeler AP, Russell JA, Schein R, Summer WR, Steinberg KP, Fulkerson WJ, Wright PE, Christman BW, Dupont WD, Higgins SB, Swindell BB, , 1997. The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group. N Engl J Med 336: 912918.[Crossref]
  10. Jegerschöld C, Pawelzik SC, Purhonen P, Bhakat P, Gheorghe KR, Gyobu N, Mitsuoka K, Morgenstern R, Jakobsson PJ, Herbert H, , 2008. Structural basis for induced formation of the inflammatory mediator prostaglandin E2 . Proc Natl Acad Sci USA 105: 1111011115.[Crossref]
  11. Bone RC, Slotman G, Maunder R, Silverman H, Hyers TM, Kerstein MD, Ursprung JJ, , 1989. Randomized double-blind, multicenter study of prostaglandin E1 in patients with the adult respiratory distress syndromes. Prostaglandin E1 Study Group. Chest 96: 114119.[Crossref]
  12. Haupt MT, Jastremski MS, Clemmer TP, Metz CA, Goris GB, , 1991. Effect of ibuprofen in patients with severe sepsis: a randomized, double-blind, multicenter study. The Ibuprofen Study Group. Crit Care Med 19: 13391347.[Crossref]
  13. World Health Organization, Communicable Diseases Cluster, 2000. Severe falciparum malaria. Trans R Soc Trop Med Hyg 94 (Suppl 1): S1S90.
  14. Silachamroon U, Krudsood S, Thanachartwet W, Tangpukdee N, Leowattana W, Chalermrut K, Srivilairit S, Wilaiaratana P, Thimasarn K, Looareesuwan S, , 2005. An open, randomized trial of three-day treatment with artesunate combined with a standard dose of mefloquine divided over either two or three days, for acute, uncomplicated falciparum malaria. Southeast Asian J Trop Med Public Health 36: 591596.
  15. Tangpukdee N, Krudsood S, Thanachartwet W, Chalermrut K, Pengruksa C, Srivilairit S, Silachamroon U, Wilairatana P, Phongtananant S, Kano S, Looareesuwan S, , 2005. An open randomized clinical trial of Artekin vs artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria. Southeast Asian J Trop Med Public Health 36: 10851091.
  16. Krudsood S, Tangpukdee N, Thanchatwet V, Wilairatana P, Srivilairit S, Pothipak N, Jianping S, Guoqiao L, Brittenham GM, Looareesuwan S, , 2007. Dose ranging studies of new artemisinin-piperaquine fixed combinations compared to standard regimens of artemisisnin combination therapies for acute uncomplicated falciparum malaria. Southeast Asian J Trop Med Public Health 38: 971978.
  17. World Health Organization, 1973. Chemotherapy of malaria and resistance to antimalarials. Report of a WHO scientific group. World Health Organ Tech Rep Ser 529: 3036.
  18. Krishna S, Pukrittayakamee S, Supanaranond W, ter Kuile F, Supputamangkol Y, Attatamsoonthorn K, Ruprah M, White NJ, , 1995. Fever in uncomplicated Plasmodium falciparum malaria: randomized double-‘blind’ comparison of ibuprofen and paracetamol treatment. Trans R Soc Trop Med Hyg 89: 507509.[Crossref]
  19. Matsiégui PB, Missinou MA, Necek M, Mavoungou E, Issifou S, Lell B, Kremsner PG, , 2008. Antipyretic effect of ibuprofen in Gabonese children with uncomplicated falciparum malaria: a randomized, double-blind, placebo-controlled trial. Malar J 7: 91.[Crossref]
  20. Brandts CH, Ndjave M, Graninger W, Kremsner PG, , 1997. Effect of paracetamol on parasite clearance time in Plasmodium falciparum malaria. Lancet 350: 704709.[Crossref]
  21. Hugosson E, Montgomery SM, Premji Z, Troye-Blomberg M, Björkman A, , 2006. Relationship between antipyretic effects and cytokine levels in uncomplicated falciparum malaria during different treatment regimes. Acta Trop 99: 7582.[Crossref]
  22. Kwiatkowski D, Molyneux ME, Stephens S, Curtis N, Klein N, Pointaire P, Smit M, Allan R, Brewster DR, Grau GE, Greenwood BM, . 1993. Anti-TNF therapy inhibits fever in cerebral malaria. Q J Med 86: 9198.
  23. van Hensbroek MB, Palmer A, Onyiorah E, Schneider G, Jaffar S, Dolan G, Memming H, Frenkel J, Enwere G, Bennett S, Kwiatkowski D, Greenwood B, , 1996. The effect of a monoclonal antibody to tumor necrosis factor on survival from childhood cerebral malaria. J Infect Dis 174: 10911097.[Crossref]
  24. Looareesuwan S, Sjostrom L, Krudsood S, Wilairatana P, Porter RS, Hills F, Warrell DA, , 1999. Polyclonal anti-tumor necrosis factor-alpha Fab used as an ancillary treatment for severe malaria. Am J Trop Med Hyg 61: 2633.
  25. Kwiatkowski D, , 1989. Febrile temperatures can synchronize the growth of Plasmodium falciparum in vitro . J Exp Med 169: 357361.[Crossref]
  26. Kwiatkowski D, , 1995 Malarial toxins and the regulation of parasite density. Parasitol Today 11: 206212.[Crossref]
  27. Kwiatkowski D, , 1993. TNF-inducing malaria toxin: a sheep in wolf's clothing? Ann Trop Med Parasitol 87: 613616.[Crossref]
  28. McGuire W, D'Alessandro U, Stephens S, Olaleye BO, Langerock P, Greenwood BM, Kwiatkowski D, , 1998. Levels of tumour necrosis factor and soluble TNF receptors during malaria fever episodes in the community. Trans R Soc Trop Med Hyg 92: 5053.[Crossref]
  29. Matsiegui PB, Missinou MA, Issifou S, Necek M, Mavoungou E, , 2007. Ibuprofen does not affect levels of tumor necrosis factor alpha and soluble tumor necrosis factor receptor types I and II in Gabonese children with uncomplicated Plasmodium falciparum malaria. Eur Cytokine Netw 18: 201205.
  30. Kwiatkowski D, Molyneux ME, Stephens S, Curtis N, Klein N, Pointaire P, Smit M, Allan R, Brewster DR, Grau GE, Greenwood BM, , 1993. Anti-TNF therapy inhibits fever in cerebral malaria. Q J Med 86: 9198.
  31. Qiu HB, Pan JQ, Zhao YQ, Chen DC, , 1997. Effects of dexamethasone and ibuprofen on LPS-induced gene expression of TNF alpha, IL-1 beta, and MIP-1 alpha in rat lung. Zhongguo Yao Li Xue Bao 18: 165168.
  32. Cazanave S, Vadrot N, Tinel M, Berson A, Lettéron P, Larosche I, Descatoire V, Feldmann G, Robin MA, Pessayre D, , 2008. Ibuprofen administration attenuates serum TNF-alpha levels, hepatic glutathione depletion, hepatic apoptosis and mouse mortality after Fas stimulation. Toxicol Appl Pharmacol 231: 336343.[Crossref]
  33. Udomsangpetch R, Pipitaporn B, Silamut K, Pinches R, Kyes S, Looareesuwan S, Newbold C, White NJ, , 2002. Febrile temperatures induce cytoadherence of ring-stage Plasmodium falciparum-infected erythrocytes. Proc Natl Acad Sci USA 99: 1182511829.[Crossref]

Data & Media loading...

  • Received : 14 Oct 2009
  • Accepted : 12 Mar 2010

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error